Growth hormone secretagogues (GHSs) stimulate GH secretion and food intake. GHS receptor (GHS-R) mRNA has been identified mainly in the arcuate nucleus (Arc) and ventromedial nucleus of the hypothalamus and in the pituitary. Ghrelin, an endogenous ligand for GHS-R, has recently been purified from rat stomach. Although ghrelin is also expressed in the hypothalamus, the physiological significance of the ghrelin/GHS-R system is still unknown. We have created transgenic (Tg) rats expressing an antisense GHS-R mRNA under the control of the promoter for tyrosine hydroxylase (TH), thus selectively attenuating GHS-R protein expression in the Arc. Tg rats had lower body weight and less adipose tissue than did control rats. Daily food intake was reduced, and the stimulatory effect of GHS treatment on feeding was abolished in Tg rats. GH secretion and plasma insulin-like growth factor-I levels were reduced in female Tg rats. These results suggest that GHS-R in the Arc is involved in the regulation of GH secretion, food intake, and adiposity.
Yujin Shuto, Tamotsu Shibasaki, Asuka Otagiri, Hideki Kuriyama, Hisayuki Ohata, Hideki Tamura, Jun Kamegai, Hitoshi Sugihara, Shinichi Oikawa, Ichiji Wakabayashi
Title and authors | Publication | Year |
---|---|---|
Neuroendocrine Profile in the Night Eating Syndrome
GS Birketvedt, A Geliebter, J Florholmen, ME Gluck |
Current Obesity Reports | 2013 |
The central nervous system sites mediating the orexigenic actions of ghrelin
BL Mason, Q Wang, JM Zigman |
Annual Review of Physiology | 2013 |
Differential pulsatile secretagogue control of GH secretion in healthy men
C Norman, J Miles, CY Bowers, JD Veldhuis |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2013 |
Obesity pharmacotherapy: current perspectives and future directions.
Misra M |
Current cardiology reviews | 2013 |